Contact
Please use this form to send email to PR contact of this press release:
Q BioMed Inc.’s Chemotherapeutic Uttroside B Shows Promising Results in Initial Pre-Clinical Testing
TO:
Keith Pinder
Landon Capital
+1 678-860-4227